Satu Kuokkanen: Thyroid Autoimmunity and Elevated TSH Linked to Lower Live Birth Rates in Infertility Trials
Satu Kuokkanen, Assistant Professor at NYU Long Island School of Medicine, shared a post on LinkedIn:
“We recently analyzed data from two major NIH-funded fertility trials (PPCOS II and AMIGOS) to explore how thyroid function markers impact pregnancy outcomes in women with infertility.
Key Finding:
Women with TSH ≥2.0 mU/L combined with TPO antibodies ≥30 U/mL had:
↓ 45% lower live birth rate
↑ Higher risk of pregnancy loss and early preterm birth
These findings may suggest that even mild thyroid dysfunction, when paired with thyroid autoimmunity, may significantly impact reproductive success—and may warrant closer screening thresholds in fertility care.
This data is hypothesis generating and therefore further research is needed, but this adds to the evidence linking thyroid health and pregnancy outcomes.
Read the full paper: Fertility and Sterility, Volume 123, Issue 5, p873-882, May 2025.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO